Search company, investor...

Geminus Therapeutics


Grant | Alive

Total Raised


Last Raised

$150K | 2 yrs ago

About Geminus Therapeutics

Geminus Therapeutics is developing Artemisinin (ART714) for treating leukemia.

Headquarters Location

Baltimore, Maryland,

United States



Geminus Therapeutics Frequently Asked Questions (FAQ)

  • Where is Geminus Therapeutics's headquarters?

    Geminus Therapeutics's headquarters is located at Baltimore.

  • What is Geminus Therapeutics's latest funding round?

    Geminus Therapeutics's latest funding round is Grant.

  • How much did Geminus Therapeutics raise?

    Geminus Therapeutics raised a total of $150K.

  • Who are the investors of Geminus Therapeutics?

    Investors of Geminus Therapeutics include Maryland Technology Development Corporation and University of Maryland.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.